OQROStart free trial
Politician trade (House)

Procter & Gamble (PG): Rep. Julia Letlow (LA05) disclosed a purchase $1K–$15K

Rep. Julia Letlow (LA05) disclosed a purchase of Procter & Gamble in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
38 days
Disclosure lag
Traded
Feb 2, 2026
Disclosed
Mar 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 16, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  2. Nov 5, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  3. Nov 13, 2025CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
  4. Nov 18, 2025CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  5. Dec 1, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
  6. Dec 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Jennifer Davis, currently Chief Executive Officer - Health Care, notified the Company of her intent to retire effective June 30, 2026, after more than 33 years of service.”
  7. Dec 18, 2025CongressDisclosed sale of PG — reported range $1,001 - $15,000
  8. Dec 24, 2025CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
  9. Jan 9, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  10. Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
  11. Jan 23, 2026InsiderOfficer sold ~$14.5M of PG shares in the open market
  12. Jan 29, 2026CongressDisclosed sale of PG — reported range $1,001 - $15,000
  13. Jan 30, 2026CongressDisclosed partial sale of PG — reported range $1,001 - $15,000
  14. Feb 2, 2026 · this disclosureCongressDisclosed purchase of PG — reported range $1,001 - $15,000

What came next

  1. Feb 4, 2026InsiderCEO sold ~$1.26M of PG shares in the open market
  2. Feb 9, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  3. Feb 11, 2026Insider · 2 peopleInsiders: 2 sales (~$3.8M)
  4. Feb 12, 2026Insider · 2 peopleInsiders: 2 sales (~$32.2M)
  5. Feb 13, 2026Insider · Their largest sale since 2021Officer sold ~$2.46M of PG shares in the open market
  6. Feb 17, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
  7. Feb 19, 2026InsiderOfficer sold ~$288K of PG shares in the open market
  8. Feb 26, 2026Congress · 2 peopleMembers of Congress: 2 sales
  9. Feb 27, 2026Insider · 1 personInsiders: 4 sales (~$917K)
  10. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  11. Apr 24, 2026Company filing · Form 8-K · ResultsReported its results
  12. Apr 27, 2026Congress · 1 personMembers of Congress: 2 purchases
  13. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Procter & Gamble

For Procter & Gamble, OQRO holds 30 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports and 75 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PG page.

Other recent filings by Rep. Julia Letlow (LA05)

The full history of Rep. Julia Letlow (LA05) is on the profile page.

How this filing works

Explore the data

Other disclosures at Procter & Gamble

Everything OQRO holds on this company is on its PG page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data